My research activities involve initiating clinical trials in renal cancer and prostate cancer, and technology assessment as applied to the introduction of minimally invasive surgery.
Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large Canadian multi-institutional database.
Can Urol Assoc J. 2019 Jul 23;:
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Jun 25;:
Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer.
Cancer Causes Control. 2019 Jul 15;:
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.
Urol Oncol. 2019 Jul 05;:
J Minim Invasive Gynecol. 2019 Jun 12;:
Negative predictive value of prostate multi-parametric magnetic resonance imaging among men with negative prostate biopsy and elevated PSA - a clinical outcome retrospective cohort study.
J Urol. 2019 Jun 12;:101097JU0000000000000388
Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2.
Urol Oncol. 2019 Jun 05;:
Epidemiology. 2019 Jul;30(4):532-540
Epidemiology. 2019 May 31;:
N Engl J Med. 2019 07 11;381(2):121-131
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Surgery and Oncology, University of Toronto
Staff Surgeon, Surgical Oncology, Division of Urology, University Health Network